EMERGENT REVERSAL OF APIXABAN WITH ANDEXANET ALFA TO FACILITATE DEBRIDEMENT OF NECROTIZING FASCIITIS

被引：0
|
作者：
Fletcher, John
Graybill, John
Alphonso, Carlos
Milling, Truman
Cap, Andrew
Alters, Kevin
机构：
来源：
CRITICAL CARE MEDICINE | 2016年 / 44卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
1708
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] FEIBA AND ANDEXANET ALFA FOR THE REVERSAL OF APIXABAN AND RIVAROXABAN IN UNCONTROLLED HEMORRHAGE
    Ice, Calvin
    Gurka, Matthew
    Parker, Jessica
    Hunt, Aleah
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 449 - 449
  • [2] Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures
    Bradshaw, Paige Garber
    Keegan, Shaun Patrick
    Droege, Molly Elizabeth
    Dykes, Nicole Jade Harger
    Ernst, Neil Edward
    Foertsch, Madeline Jane
    Makley, Amy Teres
    Mueller, Eric William
    Philpott, Carolyn Dosen
    Srinivasan, Vasisht
    Winter, Jessica Brooke
    Goodman, Michael D.
    Droege, Christopher Allen
    PHARMACOTHERAPY, 2022, 42 (10): : 780 - 791
  • [3] PHASE 3 OF ANDEXANET ALFA FOR REVERSAL OF APIXABAN AND RIVAROXABAN ANTICOAGULATION IN OLDER SUBJECTS
    Crowther, Mark
    Gold, Alex
    Lu, Genmin
    Leeds, Janet
    Wiens, Brian
    Conley, Pamela
    Connolly, Stuart
    Curnutte, John
    CRITICAL CARE MEDICINE, 2015, 43 (12)
  • [4] Reversal of Apixaban Anticoagulation with Reduced Doses of Andexanet Alfa in a Porcine Polytrauma Model
    Grottke, Oliver
    Akman, Necib
    Braunschweig, Till
    Conley, Pamela B.
    Rossaint, Rolf
    BLOOD, 2018, 132
  • [5] Andexanet Alfa: A Recombinant Modified Human Factor Xa Protein for Drug Reversal of Rivaroxaban and Apixaban
    Abuan, Irene
    Wong, Kristine H.
    Bolinske, Benjamin
    Hale, Katherine S.
    JOURNAL OF PHARMACY TECHNOLOGY, 2019, 35 (03) : 119 - 125
  • [6] Dose-Related Effectiveness of Andexanet Alfa for Reversal of Apixaban Anticoagulation in a Porcine Polytrauma Model
    Rayatdoost, Farahnaz
    Braunschweig, Till
    Schoechl, Herbert
    Rossaint, Rolf
    Grottke, Oliver
    THROMBOSIS AND HAEMOSTASIS, 2024, 124 (01) : 20 - 31
  • [7] Transient or extended reversal of apixaban anticoagulation by andexanet alfa is equally effective in a porcine polytrauma model
    Grottke, Oliver
    Braunschweig, Till
    Rossaint, Rolf
    Akman, Necib
    Leeds, Janet M.
    Conley, Pamela B.
    Honickel, Markus
    BRITISH JOURNAL OF ANAESTHESIA, 2019, 123 (02) : 186 - 195
  • [8] Coordinating emergent procedures after andexanet alfa
    Culbreth, Sarah E.
    Sylvester, Katelyn W.
    Rimsans, Jessica
    Connors, Jean M.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (10) : E278 - E282
  • [9] Andexanet Alfa for Urgent Reversal of Apixaban Before Aortic Surgery Requiring Cardiopulmonary Bypass: A Case Report
    Flaherty, Devon
    Connors, Jean M.
    Singh, Steve
    Sylvester, Katelyn W.
    Rimsans, Jessica
    Cornella, Lauren
    A & A PRACTICE, 2019, 13 (07): : 271 - 273
  • [10] Intraoperative Off-Label Reversal of Apixaban by Andexanet Alfa while on VA-ECMO Immediately After Emergent Surgery for Acute Type A Aortic Dissection
    Kainz, Matthias
    Bsuchner, Paul
    Schellongowski, Peter
    Dworschak, Martin
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2021, 35 (01) : 262 - 264
12345